MRFF Supporting ALLG Clinical Researchers

 In News

Last year, the Liberal National Government announced that they will provide $38.6 million to support 23 new clinical trials to improve treatments and discover cures for debilitating and deadly rare cancers and rare diseases.

The Rare Cancers, Rare Diseases and Unmet Need Clinical Trials program focuses on clinical trials that address areas of health burden and unmet need including blood cancer.

This funding, through our Government’s landmark Medical Research Future Fund (MRFF), aims to enhance clinical trial activity, treatments, cures, and extend and improve quality of life for Australians living with devastating conditions.

On February 15, it was announced that funding was allocated to the following ALLG Members.

  • Prof Judith Trotman’s clinical trial was awarded $787,000. The clinical trial will evaluate PET-guided, response-adapted therapy in patients with newly diagnosed advanced follicular lymphoma.
Prof Judith Trotman and the team at Concord Hospital (NSW)
Prof Judith Trotman and the team at Concord Hospital (NSW)
A/Prof Andrew Wei and the Lab Team
A/Prof Andrew Wei and the team at Alfred Hospital (VIC)
  • A/Prof Andrew Wei’s clinical trial was awarded $1,380,297.60. The clinical trial will test different treatment options aimed to improve the lives of older patients with Acute Myeloid Leukaemia.
  • Prof Maher Gandhi’s clinical trial was awarded $3,596,966.90. The clinical trial will incorporate early application of CAR-T Cells for Primary Refractory Aggressive Lymphoma.
Prof Maher Gandhi
Prof Maher Gandhi

This is the third round of grants announced the under Rare Cancers, Rare Diseases and Unmet Need Clinical Trials program taking the total funding announced under this program to $75 million.

Building on more than $36 million already announced under the Rare Cancers, Rare Diseases and Unmet Needs Clinical Trial program, the increase of funding was launched in January 2018.

The $20 billion Medical Research Future Fund was established as an endowment fund to provide a sustainable source of funding for vital medical research. It is the single largest boost in health and medical research funding in Australia’s history.

Congratulations to the three ALLG Members who have been awarded funding from the Medical Research Future Fund (MRFF) to improve treatments and discover cures for rare cancers and rare diseases. Also, a big thank you to the Medical Research Future Fund, clinical trials like these will bring hope and save lives.